Administration of a High-Dose Erythropoietin-Stimulating Agent in Hemodialysis Patients is Associated with Late Arteriovenous Fistula Failure

PURPOSE: Investigating the risk of vascular access failure is critical for maintenance hemodialysis (MHD) patients. Erythropoietin stimulating agents (ESA) typically used for anemia of chronic kidney disease (CKD) may also stimulate neointimal hyperplasia, which is the most important factor in late...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Yonsei Med J
Main Authors: Jeong, Hye Yun, Ko, Eun-Jung, Kim, Sang Hoon, Lee, Mi Jung, Cho, Hye Jeong, Yang, Dong Ho, Lee, So-Young
Formato: Artigo
Idioma:Inglês
Publicado em: Yonsei University College of Medicine 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5447111/
https://ncbi.nlm.nih.gov/pubmed/28540993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2017.58.4.793
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados